Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Prostate Cancer 2010 NCRR 1S10RR025600-01A1 MALDI TOF/TOF Mass Spectrometer for Imaging Thin Tissue Sections LOO, JOSEPH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $466,012
Prostate Cancer 2010 NIBIB 5R21EB008153-02 sPLA2 Selective Degradation of Nanoparticles CUMMINGS, BRIAN UNIVERSITY OF GEORGIA (UGA) GA $222,750
Prostate Cancer 2010 NCI 5R21CA135503-02 Determining Epigenetic Targets of Milk Thistle Extract in Prostate BUNGER, MAUREEN RESEARCH TRIANGLE INSTITUTE NC $229,131
Prostate Cancer 2010 NCI 7R21CA133807-02 Delaying the Hormone Refractory Prostate Cancer by a Dietary Triterpene Lupeol BHAT, MOHAMMAD SALEEM UNIVERSITY OF MINNESOTA TWIN CITIES MN $183,811
Prostate Cancer 2010 NCI 5R21CA133340-02 Prostate Cancer Nurse-Navigator Treatment Decision Support BROWN, NANCY PALO ALTO MEDICAL FOUNDATION RES INST CA $165,440
Prostate Cancer 2010 NCRR 1S10RR028911-01 MR-guided focused ultrasound system COAKLEY, FERGUS UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $1,368,750
Prostate Cancer 2010 NCRR 1S10RR029687-01 Ibis T-6,000 Biosensor System SEARS, CYNTHIA JOHNS HOPKINS UNIVERSITY MD $641,500
Prostate Cancer 2010 NCI 5R21CA135478-02 Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements as LIU, ZHONGFA OHIO STATE UNIVERSITY OH $197,761
Prostate Cancer 2010 NCI 5R01CA134997-02 Conjoint Analysis: Overcoming Obstacles to Routine Formal Preference Assessment i SAIGAL, CHRISTOPHER UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,548
Prostate Cancer 2010 NCI 5R21CA137725-02 Isolation and Characterization of Prostrate Antigen Specific High Affinity TCR MEHROTRA, SHIKHAR MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $194,700
Prostate Cancer 2010 NCI 5R01CA136892-02 Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the Bone ROSS, BRIAN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $543,962
Prostate Cancer 2010 NCI 5R01CA096534-06 Calcitonin in Prostate Growth and Neplasia SHAH, GIRISH UNIVERSITY OF LOUISIANA AT MONROE LA $180,250
Prostate Cancer 2010 NCI 5R21CA139079-02 Profile of Symptom Clusters Among Prostate Cancer Patients DIRKSEN, SHANNON ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $164,697
Prostate Cancer 2010 NCI 5R01CA120304-02 Ack1: Activation and Consequences in Prostate Cancer EARP, HENRY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $306,496
Prostate Cancer 2010 NCI 5R03CA139547-02 The Role of MicroRNAs in Prostate Cancer Progression KERSCHER, AURORA EASTERN VIRGINIA MEDICAL SCHOOL VA $71,750
Prostate Cancer 2010 NCI 5R01CA133241-02 PDEF and survivin: cancer prognosis, initiation, progression and metastasis LI, FENGZHI ROSWELL PARK CANCER INSTITUTE CORP NY $339,039
Prostate Cancer 2010 NCI 5R03CA139538-02 Development and Evaluation of Spatial Survival Models ZHANG, JIAJIA UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $73,926
Prostate Cancer 2010 NCI 5R01CA070297-12 Roles of the androgen receptor and its co-regulators in prostate tumorigenesis SUN, ZIJIE STANFORD UNIVERSITY CA $273,638
Prostate Cancer 2010 NCI 5R21CA133536-02 A Proteomics Approach for Identifying Predictive Factors to Androgen Deprivation KOHLI, MANISH MAYO CLINIC MN $171,384
Prostate Cancer 2010 NCI 5R03CA137667-02 FOXO: A Target for Prostate Cancer Prevention SHUKLA, SANJEEV CASE WESTERN RESERVE UNIVERSITY OH $78,500
Prostate Cancer 2010 NCI 5R21CA139329-02 Docetaxel Nanoparticles for Prostate Cancer Targeting CHENG, JIANJUN UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN IL $160,725
Prostate Cancer 2010 NCI 5R21CA143104-02 Prostate Cancer Prevention by Commiphora mukul Extract XIAO, DONG UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $199,980
Prostate Cancer 2010 NCI 5R01CA140272-02 Optimizing use of androgen deprivation therapy for prostate cancer SHAHINIAN, VAHAKN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $234,507
Prostate Cancer 2010 NCI 5R21CA132671-02 Prostate cancer health literacy in rural versus urban African-American men. KILBRIDGE, KERRY MASSACHUSETTS GENERAL HOSPITAL MA $173,278
Prostate Cancer 2010 NCI 5R21CA137272-02 Exercising Together: An intervention for prostate cancer survivors and spouses WINTERS-STONE, KERRI OREGON HEALTH AND SCIENCE UNIVERSITY OR $201,224
Prostate Cancer 2010 NIBIB 5R01EB009388-02 Real-time multiphoton microscopy of periprostatic tissue architecture TEWARI, ASHUTOSH WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $437,203
Prostate Cancer 2010 NCI 5R03CA138121-02 Imaging the effects of androgen deprivation therapy on cognitive functions in pat CHAO, HERTA YALE UNIVERSITY CT $65,200
Prostate Cancer 2010 NCI 5R01CA134655-02 Molecular cancer radiosensitization by targeting Mcl-1 XU, LIANG UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $317,094
Prostate Cancer 2010 NCI 5R01CA136535-02 Software to facilitate multimode, multiscale fused data for Pathology and Radiolo FELDMAN, MICHAEL UNIVERSITY OF PENNSYLVANIA PA $663,749
Prostate Cancer 2010 NCI 5R01CA089202-10 Prostate carcinogenesis and PKC signaling KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $317,047
Prostate Cancer 2010 NCI 5R01CA137280-02 The MT1-MMP/RANKL/RANK Axis in Prostate Cancer Bone Metastasis CHER, MICHAEL WAYNE STATE UNIVERSITY MI $461,288
Prostate Cancer 2010 NCI 5R01CA070292-12 Requirements for Normal Rb Function In Vivo GOODRICH, DAVID ROSWELL PARK CANCER INSTITUTE CORP NY $376,377
Prostate Cancer 2010 NCI 5R01CA128914-02 Inhibitor of Differentiation Gene Expression and Function in Prostate Cells CHAUDHARY, JAIDEEP CLARK ATLANTA UNIVERSITY GA $285,852
Prostate Cancer 2010 NCI 5R01CA135008-02 Interaction of germline and somatic changes in PCa progression LIU, WENNUAN WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $410,100
Prostate Cancer 2010 NCI 5R01CA133479-02 RKIP regulation as a potential for tumor suppression YEUNG, KAM UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $281,298
Prostate Cancer 2010 NCI 5R21CA141228-02 Nuclear urokinase (uPA) regulates tumor cell proliferation and survival. STEPANOVA, VICTORIA UNIVERSITY OF PENNSYLVANIA PA $176,000
Prostate Cancer 2010 NCI 5R21CA140762-02 Augmentation of NK cell-mediated anti-cancer activity by dietary BITC BASSE, PER UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $199,982
Prostate Cancer 2010 NCI 5R01CA134766-02 AR signal mediators in prostate cancer CHEN, HONGWU UNIVERSITY OF CALIFORNIA DAVIS CA $317,475
Prostate Cancer 2010 NCI 5R03CA136059-02 Dietary Inorganic Phosphate as a Target for Nutritional intervention in Cancer BECK, GEORGE EMORY UNIVERSITY GA $77,500
Prostate Cancer 2010 NCI 5R21CA144064-02 Targeting prostate cancer by inhibition of mTOR with ezhu oil JING, YONGKUI MOUNT SINAI SCHOOL OF MEDICINE NY $186,450
Prostate Cancer 2010 NCI 5R01CA133066-02 Global genetic and epigenetic approaches to progression of PCa LIU, WENNUAN WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $554,614
Prostate Cancer 2010 NCI 5R01CA076142-12 Transgenic Animal Models for Prostate Cancer MATUSIK, ROBERT VANDERBILT UNIVERSITY TN $431,377
Prostate Cancer 2010 NCI 5R01CA133620-02 Regulatory T Cells and Tumor Bone Marrow Metastasis ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $320,588
Prostate Cancer 2010 NCI 5R01CA095367-06 Vitamin D Analogs for Chemoprevention of Prostate CAncer FOSTER, BARBARA ROSWELL PARK CANCER INSTITUTE CORP NY $397,875
Prostate Cancer 2010 NLM 5R21LM010137-02 A new informatics paradigm for reconstructing signaling pathways in human disease ZHU, DONGXIAO LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS LA $200,506
Prostate Cancer 2010 NCI 5R21CA142426-02 [F18]FMAU in Prostate Cancer JADVAR, HOSSEIN UNIVERSITY OF SOUTHERN CALIFORNIA CA $178,200
Prostate Cancer 2010 OD 1R43CA150855-01 A Molecular targeting agent for systemic radiotherapy of metastatic Prostate Canc MARESCA, KEVIN MOLECULAR INSIGHT PHARMACEUTICALS, INC. MA $243,101
Prostate Cancer 2010 NCI 5R01CA141077-02 Circulating Tumor Cell Capture & Analysis in a Multi-Center Prostate Cancer Trial COTE, RICHARD UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $493,402
Prostate Cancer 2010 NIEHS 5RC2ES018758-02 Developmental Exposure to Low-dose Bisphenol A and Human Prostate Cancer Suscepti PRINS, GAIL UNIVERSITY OF ILLINOIS AT CHICAGO IL $898,116
Prostate Cancer 2010 OD 5RC1EB011001-02 Effectiveness of Robotic Compared to Standard Prostatectomy for Prostate Cancer SANDA, MARTIN BETH ISRAEL DEACONESS MEDICAL CENTER MA $500,000
Prostate Cancer 2010 NIBIB 5RC1EB010936-02 Robot-Assisted MRI-Guided Prostate Biopsy STOIANOVICI, DAN JOHNS HOPKINS UNIVERSITY MD $486,361
Prostate Cancer 2010 NIEHS 5RC2ES018789-02 Developmental Reprogramming of Prostate Carcinogenesis by BPA WALKER, CHERYL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $415,740
Prostate Cancer 2010 OD 5RC2ES018789-02 Developmental Reprogramming of Prostate Carcinogenesis by BPA WALKER, CHERYL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $540,515
Prostate Cancer 2010 NIBIB 5RC1EB011000-02 Electrical Property Based Image-guided Prostate Biopsy HALTER, RYAN DARTMOUTH COLLEGE NH $492,026
Prostate Cancer 2010 OD 5RC1CA145722-02 Evaluate long-term prognosis of localized prostate cancer following initial radia LU-YAO, GRACE UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $437,433
Prostate Cancer 2010 NIEHS 5RC1ES018097-02 Effects of pesticides on prostate cancer progression in PTEN mutant mice HENRY, MICHAEL UNIVERSITY OF IOWA IA $262,141
Prostate Cancer 2010 OD 1R15CA151031-01 Quality of Life in Prostate Cancer Project BRENNAN, CHRISTINE LOUISIANA STATE UNIV HSC NEW ORLEANS LA $374,573
Prostate Cancer 2010 NIEHS 5RC2ES018764-02 Bisphenol A: Urine flow disorder and prostate pathology VOM SAAL, FREDERICK UNIVERSITY OF MISSOURI-COLUMBIA MO $450,000
Prostate Cancer 2010 NCI 5RC1CA145444-02 Integromics with Application to Prostate Cancer Progression MICHAILIDIS, GEORGE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $499,473
Prostate Cancer 2010 NCI 5R21CA137651-02 Auto-antibody plus PSA assay for patients with prostate cancer ZENG, GANG UNIVERSITY OF CALIFORNIA LOS ANGELES CA $166,755
Prostate Cancer 2010 OD 5RC1CA146238-02 Cost-Effectiveness of Hormonal Therapy for Clinically Localized Prostate Cancer VAN DEN EEDEN, STEPHEN KAISER FOUNDATION RESEARCH INSTITUTE CA $497,496
Prostate Cancer 2010 OD 5RC1CA146596-02 Effectiveness of Early Stage Prostate Cancer Treatment SANDA, MARTIN BETH ISRAEL DEACONESS MEDICAL CENTER MA $496,220
Prostate Cancer 2010 NCI 5P30CA147880-02 Gene synergy landscapes of breast and prostate cancer LAND, HARTMUT UNIVERSITY OF ROCHESTER NY $311,547
Prostate Cancer 2010 NIDDK 5R01DK084454-02 Initiation and Regulation of Chronic Autoimmune Prostate Inflammation RATLIFF, TIMOTHY PURDUE UNIVERSITY WEST LAFAYETTE IN $325,050
Prostate Cancer 2010 NCI 5RC2CA148086-02 Biomarker Prediction of Gleason Upgrading TROCK, BRUCE JOHNS HOPKINS UNIVERSITY MD $1,050,970
Prostate Cancer 2010 NCI 5RC2CA148232-02 Application of RiboTag-seq to Exploration of Tumor Microenvironments MORRIS, DAVID UNIVERSITY OF WASHINGTON WA $876,552
Prostate Cancer 2010 NCI 5RC2CA148414-02 Comprehensive proteomic profiling of the ubiquitin pathway in cancer WOLF, DIETER SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $456,493
Prostate Cancer 2010 OD 5RC2CA148414-02 Comprehensive proteomic profiling of the ubiquitin pathway in cancer WOLF, DIETER SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $456,493
Prostate Cancer 2010 NCI 5RC1CA145864-02 Detection of Prostate Cancer Genomic Signatures in Blood KASSIS, AMIN HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $498,123
Prostate Cancer 2010 NCI 5RC1CA144825-02 Profiling and Characterizing Prostate Cancer Tumor Dormancy in the Bone Marrow VESSELLA, ROBERT UNIVERSITY OF WASHINGTON WA $499,562
Prostate Cancer 2010 OD 5RC2CA148463-02 Clinical validity and utility of genomic targeted chemoprevention of PCa XU, JIANFENG WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $2,006,440
Prostate Cancer 2010 OD 5RC1CA146516-02 Comparative Analysis of Surgical Treatment Options for Localized Prostate Cancer EASTHAM, JAMES SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $315,419
Prostate Cancer 2010 NCI 5RC1CA146849-02 Mechanism-based Classification and Targeting of Castration-Resistant Prostate Can NELSON, PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $496,917
Prostate Cancer 2010 NCI 5RC2CA148085-02 Expanding resources for understanding the genetic basis for prostate cancer in Af HAIMAN, CHRISTOPHER UNIVERSITY OF SOUTHERN CALIFORNIA CA $427,167
Prostate Cancer 2010 OD 5RC2CA148085-02 Expanding resources for understanding the genetic basis for prostate cancer in Af HAIMAN, CHRISTOPHER UNIVERSITY OF SOUTHERN CALIFORNIA CA $427,168
Prostate Cancer 2010 NIDDK 3K23DK071262-05S1 Prostate Cancer Detection by Molecular Urinalysis PAVLOVICH, CHRISTIAN JOHNS HOPKINS UNIVERSITY MD $54,000
Prostate Cancer 2010 NIDDK 3R01DK056238-08S2 The Shh-Gli Pathway Regulates Prostate Growth BUSHMAN, WADE UNIVERSITY OF WISCONSIN MADISON WI $99,458
Prostate Cancer 2010 NIBIB 1R21EB011772-01A1 Bayesian bioluminescence image reconstruction for therapy monitoring of hormone-r KLOSE, ALEXANDER COLUMBIA UNIVERSITY HEALTH SCIENCES NY $171,100
Prostate Cancer 2010 NIDDK 3R01DK040890-19S1 Development Estrogenization of the Rat Prostate Gland PRINS, GAIL UNIVERSITY OF ILLINOIS AT CHICAGO IL $8,950
Prostate Cancer 2010 NIDDK 3R01DK076602-05S1 Progenitor cells of the mouse prostate epithelium SHEN, MICHAEL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $99,783
Prostate Cancer 2010 OD 1RC4CA155806-01 CANTRANce: A tool to translate intermediate endpoints to mortality in CE studies ETZIONI, RUTH FRED HUTCHINSON CANCER RESEARCH CENTER WA $1,091,952
Prostate Cancer 2010 NIDDK 3R01DK052659-10S1 Tyrosine Kinases and Prostate Cancer KUNG, HSING-JIEN UNIVERSITY OF CALIFORNIA DAVIS CA $87,554
Prostate Cancer 2010 NIEHS 3RC2ES018758-01S1 Developmental Exposure to Low-dose Bisphenol A and Human Prostate Cancer Suscepti PRINS, GAIL UNIVERSITY OF ILLINOIS AT CHICAGO IL $11,241
Prostate Cancer 2010 NIEHS 3RC2ES018789-01S1 Developmental Reprogramming of Prostate Carcinogenesis by BPA WALKER, CHERYL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $7,355
Prostate Cancer 2010 NLM 3R21LM010137-01S1 A new informatics paradigm for reconstructing signaling pathways in human disease ZHU, DONGXIAO LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS LA $90,292
Prostate Cancer 2010 NIEHS 3RC2ES018764-01S1 Bisphenol A: Urine flow disorder and prostate pathology VOM SAAL, FREDERICK UNIVERSITY OF MISSOURI-COLUMBIA MO $43,558
Prostate Cancer 2010 NIEHS 3RC2ES018758-01S2 Developmental Exposure to Low-dose Bisphenol A and Human Prostate Cancer Suscepti PRINS, GAIL UNIVERSITY OF ILLINOIS AT CHICAGO IL $86,242
Prostate Cancer 2010 NIEHS 3RC2ES018764-02S1 Bisphenol A: Urine flow disorder and prostate pathology VOM SAAL, FREDERICK UNIVERSITY OF MISSOURI-COLUMBIA MO $183,185
Prostate Cancer 2010 NCRR 3P30CA022453-28S5 0006 Proteases Program SLOANE, BONNIE WAYNE STATE UNIVERSITY MI $7,541


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer